Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Rules to Target RNA Are Focus of Research

19.12.2005


Once described as DNA’s less-famous chemical cousin, RNA, or ribonucleic acid, recently has moved to center stage.



RNA, the genetic material that circulates throughout cells, orchestrates the building of proteins based on instructions provided by DNA, catalyzes chemical reactions and can alter expression of proteins that may lead to cancer and other diseases.

But finding compounds that bind to and inhibit an RNA sequence -- as a potential new approach to designing disease treatments -- is still very much a trial-and-error process, involving the tedious screening of millions of molecules against a single RNA sequence.


Now, a University at Buffalo medicinal chemist is hoping to change that.

Matthew D. Disney, Ph.D., assistant professor in the Department of Chemistry in UB’s College of Arts and Sciences, is working to develop rules for targeting RNA. These rules could be used in the rational design of compounds to inhibit a specific RNA sequence.

Disney’s goal, with the help of a five-year, $50,000 new faculty award from the Camille & Henry Dreyfus Foundation, is to develop a chemical code to enable rational design of binders to any RNA structure. His work also is funded by the New York State Center of Excellence in Bioinformatics and Life Sciences.

"What we would like to do is develop a general set of tools that can take an RNA sequence and design efficiently a compound that can turn its activity off," explained Disney.

The human genome and other sequencing efforts have uncovered a lot of sequence information, he continued, but the question, he asks, is, "How can that information be best exploited?"

"One answer may be to take RNA sequence information and design drugs that target that sequence," said Disney. "If that can be done, then a lot of the expense in designing new drugs goes out the window."

Potentially, that could facilitate the development of compounds to treat diseases ranging from antibiotic-resistant bacterial infections to cancer and genetic diseases, such as sickle cell anemia and cystic fibrosis, Disney said.

Rationally designed RNA inhibitors could, he explained, prove more valuable than molecules that inhibit DNA.

One reason is that while DNA bases or nucleotides are always paired according to the same formula, RNA bases have more diverse pairings, which makes targeting RNA more challenging, but also potentially more valuable.

"The ability to form different pairings allows RNA to have a much larger structural repertoire than DNA and that gives RNA the ability to have such diverse cellular functions," said Disney.

In addition, he said, because DNA is present only in the nucleus, pharmaceutical compounds that target it must be able to penetrate the nucleus.

"Since RNA is present both in the cell’s nucleus and cytoplasm, you do not need to get a compound into the nucleus to target it," he said.

Because RNA folds more like a protein than DNA does, it also may be easier to design compounds that selectively target specific structures, he added.

Disney lives in Williamsville.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York.

Ellen Goldbaum | EurekAlert!
Further information:
http://www.buffalo.edu

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>